Accession Number: | 0001209191-19-053497 |
Date: | 2019-10-15 |
Issuer: | NEKTAR THERAPEUTICS (NKTR) |
Original Submission Date: |
LABRUCHERIE GIL M
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-10-15 | M | 25,000 | a | $7.21 | 252,872 | direct | ||
COMMON STOCK | 2019-10-15 | S | 25,000 | d | $15.83 | 227,872 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 7.21 | 2019-10-15 | deemed execution date | M | 25,000 (d) | 2016-02-08 | 2020-02-07 | common stock 25,000 | $7.21 | 25,000 | direct |
ID | footnote |
---|---|
f1 | this transaction was made pursuant to a rule 10b5-1 trading plan adopted by mr. labrucherie for stock options scheduled to expire on february 7, 2020. |
f2 | this number includes 997 shares held by the reporting person in the issuer's 401(k) plan and 4,218 shares held by the reporting person in the issuer's espp plan. the acquisition of these shares under both plans is exempt under rule 16b-3(c). |